David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...